Diagnosed with advanced lung cancer, Renee joined an immunotherapy clinical trial led by Dr. LoRusso that saved her life. Read the story and watch the video.
Deadline: Aug. 3This award recognizes a scientist who has made a far-reaching impact in the field of cancer immunology.
Offering practical knowledge and real hope to cancer patients, survivors, and caregivers.
Abstract Deadline: Wed., June 22, 2016Attend this meeting to discuss innovations in drug development, target selection, and molecular biology.
Registration Deadline: June 13Discussing research from basic science to therapeutics
This Cancer Research Catalyst blog contains the editorial by AACR President Nancy Davidson that appeared in May 20, edition of The Cancer Letter, in which Davidson discusses her goals for the year.
Abemaciclib for Patients with Breast, Lung, and Other Cancers
AACR CEO Margaret Foti Honored With Ovarcome Excellence Award
American Association for Cancer Research Returns as Charity Title Partner of Rock ‘n’ Roll Philadelphia Half Marathon
Investigational CDK4/6 Inhibitor Abemaciclib is Active Against a Range of Cancer Types
San Antonio Breast Cancer Symposium
CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research